New HIV diagnoses in Ontario, 2014

Similar documents
WISCONSIN AIDS/HIV PROGRAM NOTES

The HIV/AIDS Epidemic in California s Latino Population

HIV Surveillance Update

HIV prevention and the wider UK population. What HIV prevention work should be directed towards the general population in the UK?

West Virginia HIV/AIDS Surveillance Report 2009 Update West Virginia HIV/AIDS Program

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

HIV/AIDS In the Houston Area

M I L L I O N S Figure 2.1 Number of people newly infected with HIV

Georgia HIV/AIDS Surveillance Summary. Data Through December 31, 2010


HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida, 2014

Drug Abuse Trends in the Seattle/King County Area: 2013

HIV New Diagnoses, Treatment and Care in the UK 2015 report

Impact of Diabetes on Treatment Outcomes among Maryland Tuberculosis Cases, Tania Tang PHASE Symposium May 12, 2007

HIV/AIDS Epidemiology Report

Injection Drug Users in Miami-Dade: NHBS-IDU2 Cycle Preliminary Results

Using HIV Surveillance Data to Calculate Measures for the Continuum of HIV Care

HIV Epidemiology in New York State

Estimates of New HIV Infections in the United States

Hepatitis C Infections in Oregon September 2014

Injection Drug Use, HIV and HCV Infection in Ontario: The Evidence 1992 to 2004

HIV& AIDS BASIC FACTS. HIV & Drug Use. You are better off knowing if you have HIV. HIV & Sex. What are HIV & AIDS? HIV & Blood Products

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

Mid-year population estimates. Embargoed until: 20 July :30

Educational Attainment of Veterans: 2000 to 2009

2011 STI Annual Report

Massachusetts HIV Drug Assistance Program (HDAP) and Comprehensive Health Insurance Initiative (CHII) Application Form

Drug Abuse Trends in the Seattle/King County Area: 2013

Drug Use and Abuse in San Diego County, California: 2013

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

EXECUTIVE SUMMARY: INTEGRATED EPIDEMIOLOGIC PROFILE FOR HIV/AIDS PREVENTION AND CARE ELIGIBLE METROPOLITAN AREA PLANNING, PHILADELPHIA

Gonneke Hermanides, MD Izzy Gerstenbluth, MD epidemiologist

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report Sweden

Annual Surveillance Report 2014 Supplement

Patterns and Trends of Drug Abuse in the Baltimore/Maryland/Washington, DC, Metropolitan Area Epidemiology and Trends:

Assertive outreach enhances hepatitis B vaccination for people who inject drugs in Melbourne, Australia

Saint Louis Encephalitis (SLE)

Hepatitis C. Screening, Diagnosis and Linkage to Care

Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services

New Brunswick Health Indicators

Integrating Medical Care Coordination Services into HIV Clinic Medical Homes

Annual Epidemiological Spotlight on HIV in London 2014 data

Meningococcal Disease Among Men Who Have Sex with Men United States, January June 2015

Saint Louis Encephalitis (SLE)

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

Egg and sperm donation in the UK:

Health Issues Affecting Older Gay, Lesbian and Bisexual People in the UK

Guidelines for Viral Hepatitis CTR Services

Statistical Snapshot of Lawyers in Ontario from the Lawyer Annual Report (LAR) 2013

Targeted HIV Testing & Enhanced Testing Technologies. HIV Prevention Section Bureau of HIV/AIDS

STOP HIV/AIDS Quarterly Monitoring Report

Chapter 15 Multiple myeloma

4/3/2012. Surveillance. Direct Care. Prevention. Quality Management

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for

The Epidemiology of Hepatitis A, B, and C

Understanding the HIV Care Continuum

Condoms, PrEP, and the use of ART to prevent the sexual transmission of HIV: Overview of the science and recommendations for service providers

GARPR Online Reporting Tool

Chapter 20: Analysis of Surveillance Data

Injuries and Violence

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

A Ministry of the Archdiocese of Galveston-Houston A United Way Agency

Hepatitis C Virus Infection: Prevalence Report, 2003 Data Source: Minnesota Department of Health HCV Surveillance System

Figure 1.1 Percentage of persons without health insurance coverage: all ages, United States,

A PLAN FOR HOUSING THE FLORIDA CONSORTIUM FOR HIV/AIDS RESEARCH AT THE AIDS INSTITUTE. Background

Maryland HIV Plan

Monitoring Program (DMP) heroin purchase data (edited versions) were also utilized. Data were also obtained from the Threat Assessment Report

I. DEMOGRAPHIC DETERMINANTS OF POPULATION AGEING

PEER REVIEW HISTORY ARTICLE DETAILS TITLE (PROVISIONAL)

Minnesota HIV/AIDS Epidemiologic Profile

GONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1)

Module 4: Formulating M&E Questions and Indicators

Program Performance Indicators Revised Baseline & Target Setting Form January 1 June 30, 2004 Interim Progress Report

STOP HIV/AIDS Quarterly Monitoring Report

SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS

Aim of Presentation. The Role of the Nurse in HIV Care. Global Epidemic 7/24/09

5.0 Provincial and Territorial Government Health Expenditure by Age and Sex

The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011

Completeness of Physician Billing Claims for Diabetes Prevalence Estimation

Statistical release P0302

Age In London TB is more common in younger adults aged years and peaks in the age group (3).

Nancy Glick, MD. Karen Reitan, MA

March ABSTRACT

Scottish Diabetes Survey Scottish Diabetes Survey Monitoring Group

Over-Age, Under-Age, and On-Time Students in Primary School, Uganda

SUMMARY- REPORT on CAUSES of DEATH: in INDIA

TREATMENT OF STI CONTACTS

Epidemiology of HCV and HIV/HCV Infection in Guangzhou, China. Title. Charles Wang, M.D.

SURVEILLANCE REPORT. Hepatitis B and C surveillance in Europe.

APPENDIX C Process Monitoring and Evaluation Tools

HIV/AIDS AND OTHER SEXUALLY TRANSMITTED INFECTIONS 11

READINESS ASSESSMENT MOVING TOWARDS A COUNTRY-LED AND -FINANCED HIV RESPONSE FOR KEY POPULATIONS HEALTH POLICY P R O J E C T

HIV Prevention Needs Assessment for London

Generational differences in timing of first MSM-specific prevention advice among MSM in Switzerland

Q&A on methodology on HIV estimates

IV. DEMOGRAPHIC PROFILE OF THE OLDER POPULATION

Case-Control Studies. Sukon Kanchanaraksa, PhD Johns Hopkins University

Age/sex/race in New York State

Ending the Epidemic in New York State. Federal AIDS Policy Partnership March 4, 2015

Transcription:

New HIV diagnoses in Ontario, 2014 Mark Gilbert, MD Applied Epidemiology Unit, Ontario HIV Treatment Network November 2015

What can you expect to learn? To understand what the trends are in new HIV diagnoses for Ontario up to 2014 To understand some of the limitations of this information

Where does this data come from?

Source of information 1. Person decides to get an HIV test 2. Health care provider completes a lab form 3. Specimen is collected and sent to Public Health Ontario Laboratory 4. If the result is HIV positive: Result reported back to health care provider to give result to the person, and to local public health unit Result is shared with the Laboratory Enhancement Program, which sends a data collection form to the health care provider Information on form Information on form 4

What is a new HIV diagnosis? Based on having a first positive HIV test in Ontario Not the same thing as a new HIV infection Includes people already diagnosed with HIV who have moved and tested for the first time in Ontario 5

William W. Watt 6

25% of new HIV diagnoses are missing information on risk factors 40% are missing information on ethnicity No option for documenting transgender identity 7

HIV diagnoses by Sex 8

Total HIV diagnoses, 2005-2014 1,400 Number of HIV diagnoses 1,200 1,000 800 1,106 1,132 1,048 1,101 996 1,025 1,003 869 815 837 600 400 200 0 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 9

HIV diagnoses by sex, 2005-2014 1,000 Number of HIV diagnoses Male Female 800 828 797 805 825 762 813 779 674 671 656 600 400 200 270 328 236 270 225 194 209 190 138 174 0 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca); Cases with unknown sex excluded; no option for transgender 10

HIV diagnoses by Age group 11

25% HIV diagnoses by age group and sex, 2012-2014 Percent of HIV diagnoses Male Female 20% 15% 10% 5% 0% <15 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70+ Age group (years) Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 12

Female HIV diagnoses by age group and time period, 1995-2014 30% 25% Percent of HIV diagnoses Time period: 1995-1999 2000-2004 2005-2009 2010-2014 20% 15% 10% 5% 0% <10 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70+ Age group (years) Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 13

Female HIV diagnoses by age group and time period, 1995-2014 30% 25% Percent of HIV diagnoses Time period: 1995-1999 2000-2004 2005-2009 2010-2014 20% 15% 10% 5% 0% <10 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70+ Age group (years) Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 14

Male HIV diagnoses by age group and time period, 1995-2014 30% 25% Percent of HIV diagnoses Time period: 1995-1999 2000-2004 2005-2009 2010-2014 20% 15% 10% 5% 0% <10 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70+ Age group (years) Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 15

Male HIV diagnoses by age group and time period, 1995-2014 30% 25% Percent of HIV diagnoses Time period: 1995-1999 2000-2004 2005-2009 2010-2014 20% 15% 10% c 5% 0% <10 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70+ Age group (years) Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 16

Male (not known to be MSM) HIV diagnoses by age group and time period, 1995-2014 30% 25% Percent of new HIV Time period: diagnoses 1995-1999 2000-2004 2005-2009 2010-2014 20% 15% 10% 5% 0% <10 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70+ Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca); MSM=men who have sex with men 17

Male (known to be MSM) HIV diagnoses by age group and time period, 1995-2014 30% 25% 20% Percent of new HIV diagnoses Time period: 1995-1999 2000-2004 2005-2009 2010-2014 15% 10% c 5% 0% <10 10-14 15-19 20-24 25-29 30-34 35-39 40-44 45-49 50-54 55-59 60-64 65-69 70+ Age group (years) Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca); MSM=men who have sex with men 18

HIV diagnoses by Health Region 19

Health Regions

HIV diagnoses by Health Region, 2014 600 Number of HIV diagnoses 500 484 434 400 300 200 100 0 111 82 91 87 72 78 71 66 17 25 18 21 Northern Ottawa Eastern Toronto Central East Central West Southwest Average 2012-2013 2014 Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 21

Male HIV diagnoses by Health Region, 2014 450 400 350 300 250 200 150 Number of HIV diagnoses 401 362 100 50 0 85 58 67 61 60 56 55 49 14 15 15 14 Northern Ottawa Eastern Toronto Central East Central West Southwest Average 2012-2013 2014 Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 22

Female HIV diagnoses by Health Region, 2014 90 80 Number of HIV diagnoses 80 70 68 60 50 40 30 20 10 0 25 23 23 24 22 16 17 10 12 7 <5 <5 Northern Ottawa Eastern Toronto Central East Central West Southwest Average 2012-2013 2014 Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 23

HIV diagnoses by population (exposure category) 24

Missing information on exposure category 25% 75% 25

HIV diagnoses by exposure category 2005-2014 (where known) 100% 90% 80% 70% 60% 50% 40% 30% Percent of HIV diagnoses 61% 2005-06 2007-08 2009-10 2011-12 2013-14 20% 10% 0% 13% 14% 8% 4% 0% MSM MSM-PWID PWID HIV-Endemic Heterosexual Other Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca); MSM=men who have sex with men, PWID=people who inject drugs 26

Male HIV diagnoses by exposure category 2005-2014 (where known) 100% 90% 80% 70% 60% 50% 40% 30% Percent of HIV diagnoses 73% 2005-06 2007-08 2009-10 2011-12 2013-14 20% 10% 0% 11% 5% 6% 5% 0% MSM MSM-PWID PWID HIV-Endemic Heterosexual Other Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca); MSM=men who have sex with men, PWID=people who inject drugs 27

Female HIV diagnoses by exposure category 2004-2014 (where known) 100% 90% 80% 70% 2005-06 2007-08 2009-10 2011-12 2013-14 60% 50% 48% 40% 30% 33% 20% 10% 0% 18% PWID HIV-Endemic Heterosexual Other 1% Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca); PWID=people who inject drugs 28

HIV diagnoses by ethnicity 29

Missing information on ethnicity 40% 60% 30

HIV diagnoses by ethnicity 2009-2014 (where known) 70% Percent of HIV diagnoses 2009-2010 2011-2012 60% 50% 40% 52% 2013-2014 30% 20% 21% 10% 0% 2% 7% 4% 2% 9% 3% Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 31

Male HIV diagnoses by ethnicity 2009-2014 (where known) 70% 60% 50% Percent of HIV diagnoses 2009-2010 56% 2011-2012 2013-2014 40% 30% 20% 10% 0% 15% 2% 8% 4% 3% 10% 3% Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 32

Female HIV diagnoses by ethnicity 2009-2014 (where known) 70% 60% 50% 40% 30% Percent of HIV diagnoses 2009-2010 32% 51% 2011-2012 2013-2014 20% 10% 0% 4% 2% 4% 1% 4% 2% Data provided by Public Health Ontario Laboratory to OHESI (www.ohesi.ca) 33

To summarize 34

Take-home messages for 2014 New HIV diagnoses by exposure category Consistent with long term trends Small changes in 2013-14 compared to previous two years, except among females who use injection drugs New HIV diagnoses by ethnicity Varying trends in 2013-14 compared to prior two-year periods Difficult to interpret due to missing data 35

Take-home messages for 2014 New HIV diagnoses in females: Peak age 30-34, with shift to older age at diagnosis over time Small increase in diagnoses in females compared to 2013 yet still lower than previous years Small increase in Northern, Eastern, and Central West Health Regions Small increase among females who use injection drugs Possible explanations? Small increases between years are not uncommon (usual variation)? Efforts to increase testing among females who use injection drugs? 36

Take-home messages for 2014 New HIV diagnoses in males: Stable number of new HIV diagnoses compared to 2013 Two trends by age: Cohort effect: men born in 1960 s have higher number of diagnoses compared to other generations (more pronounced in MSM) Shift towards younger age at diagnosis among MSM over past 10 years Explanations? Consistent with trends seen in other places Reflects generational differences, including underlying HIV prevalence? 37

What s next? Looking further into these trends Working to change lab form to reducing missing information Looking at ways to adjust for missing data Shifting from mutually exclusive exposure categories to overlapping priority populations 38

Thanks for watching! mgilbert@ohtn.on.ca @mpjgilbert For more information or to register for updates, please visit www.ohesi.ca 39